ALK/EGFR-IN-2 is a potent dual inhibitor of ALK and EGFR; it induces cancer cell apoptosis and G0/G1 cell cycle arrest; it significantly inhibits the proliferation of H1975, PC9, and Baf3-EML4-ALK cancer cell lines with IC50 values of 0.0034, 0.0065, and 0.0018 μM, respectively.